VERTEX PHARMACEUTICALS INC / MA — Director's Dealing 2012

Nov 8, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VERTEX PHARMACEUTICALS INC / MA (VRTX)
CIK: 0000875320
Period of Report: 2012-11-07

Reporting Person: MCGLYNN MARGARET G (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-11-07	Common Stock	P	1000	$45.50	Acquired	1000	Direct

Footnotes

F1: Open market purchases reported on this line occurred at a weighted average price of $45.50 (range $45.22 to $45.71).

F2: Ms. McGlynn undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares purchased at each separate price.